Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$89.22

0.75 (0.85%)

, CHRS

Coherus Biosciences

07:12
09/15/17
09/15
07:12
09/15/17
07:12

AbbVie price target raised to $107 from $94 at Jefferies

Jefferies analyst Jeffrey Holford raised his price target for AbbVie (ABBV) to $107 after Coherus Biosciences (COHR) failed to gain institution of an inter partes review on a key formulation Humira patent. The analyst says his two-stage thesis on AbbVie has been that consensus expectations for U.S. Humira biosimilars would be pushed back, allowing investors to "finally focus" on the value inside the rest of the company and the pipeline. In a research note titled "Stage I Complete; More Upside on Offer from Stage II," Holdford reiterates AbbVie as his Top Pick with a Buy rating.

ABBV

AbbVie

$89.22

0.75 (0.85%)

CHRS

Coherus Biosciences

  • 25

    Sep

  • 27

    Sep

ABBV AbbVie
$89.22

0.75 (0.85%)

09/08/17
MAXM
09/08/17
NO CHANGE
MAXM
Coherus Biosciences price target lowered to $20 from $40 at Maxim
Maxim analyst Jason McCarthy cut his price target on Coherus (CHRS) after several petitions for Inter Partes review of AbbVie's (ABBV) Humira were denied. As a result of this development, the analyst thinks that Coherus may not be able to launch its CHS-1420 "for years" after its approval which he believes could come in 2019.
09/11/17
COWN
09/11/17
NO CHANGE
Target $95
COWN
Market Perform
AbbVie price target raised to $95 from $70 at Cowen
Cowen analyst Steve Scala raised his price target on Abbvie to $95 from $70 to reflect his raised estimates to account for higher Humira forecasts. The company received an important victory regarding an IPR targeting a Humira formulation, which he feels will allow Abbvie to hold Humira sales at least flat during 2020-2022. This has big bottom line implications, said Scala, who maintained his Market Perform rating on Abbvie shares.
09/13/17
RHCO
09/13/17
NO CHANGE
RHCO
AbbVie data increases confidence in RA opportunity, says SunTrust
SunTrust analyst John Boris says that data on AbbVie's (ABBV) UPAD for rheumatoid arthritis shows that its efficacy "appears competitive" with that of Pfizer's (PFE) Xeljanz/XR. The analyst says that the data increases his confidence in AbbVie's opportunity in RA. He keeps a $95 price target and a Buy rating on the shares.
09/15/17
PIPR
09/15/17
NO CHANGE
Target $100
PIPR
Overweight
AbbVie price target raised to $100 from $85 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss raised his price target for AbbVie (ABBV) to $100 after pushing out a U.S. biosimilar entry for Humira by two years. The recent denials by the Patent Trial and Appeal Board of all four of Coherus Bioscience's (CHRS) inter partes review petitions reinforce the patentability of Humira's formulation, Purkiss tells investors in a research note. The analyst pushed out his view of the likely timing of the first U.S. biosimilar launch versus Humira to the second half of 2022 from the second half of 2020. He estimates Humira will still account for 58% of AbbVie's total revenue in 2020. The analyst reiterates an Overweight rating on the shares.
CHRS Coherus Biosciences

06/13/17
FBCO
06/13/17
NO CHANGE
Target $24
FBCO
Outperform
Coherus price target lowered to $24 from $38 at Credit Suisse
Credit Suisse analyst Alethia Young lowered her price target on Coherus Biosciences to $24 from $38, stating that there is greater risk around the development path for its Neulasta biosimilar after the FDA's complete response letter. Young reiterates that she is "cautiously optimistic" the company can address issues over the next six months, though that makes this time period critical for CHS-1701. For now, she has decreased her probability of success for CHRS-1701 to 65% from 90% in U.S. and Europe, though she keeps an Outperform rating on Coherus shares.
07/10/17
KEYB
07/10/17
DOWNGRADE
KEYB
Sector Weight
Medpace downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Donald Hooker downgraded Medpace Holdings (MEDP) to Sector Weight ahead of the Q2 earnings report citing valuation. The analyst also believes issues at "important" client Coherus Biosciences (CHRS) could adversely impact the relationship in the near term. Hooker views 2017 as a "rocky year" and recommends "temporarily" stepping to the sidelines with respect to Medpace shares.

TODAY'S FREE FLY STORIES

TOSBF

Toshiba, also use TOSYY

, TOSYY

Toshiba, also use TOSBF

$16.95

-0.01 (-0.06%)

19:11
01/17/18
01/17
19:11
01/17/18
19:11
Periodicals
Toshiba's Westinghouse to forgo bankruptcy, Reuters reports »

Westinghouse Electric…

TOSBF

Toshiba, also use TOSYY

TOSYY

Toshiba, also use TOSBF

$16.95

-0.01 (-0.06%)

BAM

Brookfield

$43.10

0.42 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$70.20

0.22 (0.31%)

, RDS.B

Royal Dutch Shell

$72.34

0.35 (0.49%)

19:02
01/17/18
01/17
19:02
01/17/18
19:02
Periodicals
Shell, BP each agree to purchase Libyan oil, Bloomberg reports »

Royal Dutch Shell (RDS.A)…

RDS.A

Royal Dutch Shell

$70.20

0.22 (0.31%)

RDS.B

Royal Dutch Shell

$72.34

0.35 (0.49%)

BP

BP

$42.88

0.42 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AAPL

Apple

$179.10

2.91 (1.65%)

18:31
01/17/18
01/17
18:31
01/17/18
18:31
Hot Stocks
Trump says Apple investments 'huge win for American workers' »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

MPVD

Mountain Province Diamonds

$2.83

0.075 (2.73%)

18:22
01/17/18
01/17
18:22
01/17/18
18:22
Hot Stocks
Mountain Province Diamonds provides update on Gahcho Kue Mine exploration »

Mountain Province…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAC

Walter Investment

$0.76

0.0347 (4.81%)

18:17
01/17/18
01/17
18:17
01/17/18
18:17
Hot Stocks
Walter Investment prepackaged Chapter 11 plan approved by court »

Walter Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$140.72

2.75 (1.99%)

, KBSTY

Kobe Steel

18:10
01/17/18
01/17
18:10
01/17/18
18:10
Periodicals
Toyota not affected by Kobe Steel false data scandal, Nikkei reports »

Toyota (TM) said there…

TM

Toyota

$140.72

2.75 (1.99%)

KBSTY

Kobe Steel

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBOE

Cboe Global Markets

$131.52

0.73 (0.56%)

, BTC

Bitcoin

17:47
01/17/18
01/17
17:47
01/17/18
17:47
Hot Stocks
Cboe conducts first settlement of Cboe bitcoin futures »

Cboe Global Markets…

CBOE

Cboe Global Markets

$131.52

0.73 (0.56%)

BTC

Bitcoin

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

GWRE

Guidewire

$75.64

0.19 (0.25%)

17:46
01/17/18
01/17
17:46
01/17/18
17:46
Hot Stocks
Guidewire director sells 6,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.10

2.91 (1.65%)

17:40
01/17/18
01/17
17:40
01/17/18
17:40
Recommendations
Apple analyst commentary  »

Apple cash repatriation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

OBE

Obsidian Energy

$1.21

-0.03 (-2.42%)

17:36
01/17/18
01/17
17:36
01/17/18
17:36
Hot Stocks
Breaking Hot Stocks news story on Obsidian Energy »

FrontFour reports 5.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SN

Sanchez Energy

$5.81

0.16 (2.83%)

17:33
01/17/18
01/17
17:33
01/17/18
17:33
Hot Stocks
Breaking Hot Stocks news story on Sanchez Energy »

Sanchez Energy sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

SN

Sanchez Energy

$5.81

0.16 (2.83%)

17:32
01/17/18
01/17
17:32
01/17/18
17:32
Hot Stocks
Sanchez Energy sees FY18 capital budget of $420M-$470M »

Sanchez Energy 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

NTDOY

Nintendo

$51.53

1.55 (3.10%)

17:32
01/17/18
01/17
17:32
01/17/18
17:32
Hot Stocks
Nintendo announces Nintendo Labo accessories for Switch consoles »

Nintendo introduced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

PTC

PTC

$66.70

1.41 (2.16%)

, ESIO

Electro Scientific

$22.01

1.91 (9.50%)

17:28
01/17/18
01/17
17:28
01/17/18
17:28
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: PTC…

PTC

PTC

$66.70

1.41 (2.16%)

ESIO

Electro Scientific

$22.01

1.91 (9.50%)

NEOT

Neothetics

$1.92

0.0793 (4.31%)

PLXS

Plexus

$64.36

0.59 (0.93%)

AA

Alcoa

$56.99

0.75 (1.33%)

SLM

Sallie Mae

$11.49

0.02 (0.17%)

ARWR

Arrowhead

$5.72

0.12 (2.14%)

PRTK

Paratek Pharmaceuticals

$17.68

-0.075 (-0.42%)

IIPR

Innovative Industrial Properties

$31.30

-2.49 (-7.37%)

ECC

Eagle Point Credit

$19.13

-0.39 (-2.00%)

AGIO

Agios Pharmaceuticals

$70.33

1.53 (2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 07

    Feb

  • 26

    Feb

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

BTU

Peabody Energy

$40.00

0.42 (1.06%)

17:17
01/17/18
01/17
17:17
01/17/18
17:17
Hot Stocks
Breaking Hot Stocks news story on Peabody Energy »

Discovery Capital reduces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

MLNX

Mellanox

$64.30

-0.45 (-0.69%)

17:12
01/17/18
01/17
17:12
01/17/18
17:12
Hot Stocks
Starboard to nominate nine directors for election at Mellanox »

Starboard Value, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

APHB

AmpliPhi

$1.12

0.03 (2.75%)

17:11
01/17/18
01/17
17:11
01/17/18
17:11
Syndicate
AmpliPhi requests withdrawal of registration statement »

AmpliPhi confirms that no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$146.98

0.12 (0.08%)

17:05
01/17/18
01/17
17:05
01/17/18
17:05
Hot Stocks
Johnson & Johnson issues statement on ZYTIGA Inter Partes reviews »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

EVEP

EV Energy

$0.89

0.015 (1.71%)

17:03
01/17/18
01/17
17:03
01/17/18
17:03
Hot Stocks
EV Energy announces extension of grace period to meet NASDAQ requirement »

EV Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBM

Hudbay Minerals

$10.05

0.1 (1.01%)

17:02
01/17/18
01/17
17:02
01/17/18
17:02
Hot Stocks
Hudbay Minerals sees FY18 CapEx $245M »

Hudbay Minerals released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFE

Safeguard Scientifics

$10.85

-0.15 (-1.36%)

17:02
01/17/18
01/17
17:02
01/17/18
17:02
Hot Stocks
Safeguard Scientifics to implement changes in business strategy and operations »

Safeguard Scientifics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSI

Motorola Solutions

$97.28

1.42 (1.48%)

, SSTI

ShotSpotter

$16.10

0.06 (0.37%)

16:55
01/17/18
01/17
16:55
01/17/18
16:55
Hot Stocks
Motorola Solutions reports 9.8% passive stake in ShotSpotter »

In a regulatory filing,…

MSI

Motorola Solutions

$97.28

1.42 (1.48%)

SSTI

ShotSpotter

$16.10

0.06 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ERIE

Erie Indemnity

$117.23

1.44 (1.24%)

16:52
01/17/18
01/17
16:52
01/17/18
16:52
Hot Stocks
Erie Indemnity sees $20M in tax expense as a result of new tax law »

Erie Indemnity expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.10

2.91 (1.65%)

16:52
01/17/18
01/17
16:52
01/17/18
16:52
Periodicals
Apple to issue $2,500 restricted stock bonuses to workers, Bloomberg says »

Apple informed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SLM

Sallie Mae

$11.49

0.02 (0.17%)

16:51
01/17/18
01/17
16:51
01/17/18
16:51
Earnings
Sallie Mae reports Q4 core EPS 19c, consensus 19c »

Reports Q4 GAAP net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.